CD8A and neoplasm: Exploratory analyses of baseline tumor biomarkers in a small subset of patients in PIVOT-02 showed that higher levels of CD8+ TILs and a higher interferon gamma (IFN-γ) gene expression profiling signature were associated with greater objective response rates (ORR) and improved progression-free survival (PFS)13.